Annual EBIT
-$45.28 M
+$16.52 M+26.73%
December 31, 2023
Summary
- As of February 7, 2025, RXST annual earnings before interest & taxes is -$45.28 million, with the most recent change of +$16.52 million (+26.73%) on December 31, 2023.
- During the last 3 years, RXST annual EBIT has fallen by -$73.42 million (-260.90%).
- RXST annual EBIT is now -135.86% below its all-time high of $126.27 million, reached on December 31, 2019.
Performance
RXST EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$6.32 M
-$263.00 K-4.34%
September 30, 2024
Summary
- As of February 7, 2025, RXST quarterly earnings before interest & taxes is -$6.32 million, with the most recent change of -$263.00 thousand (-4.34%) on September 30, 2024.
- Over the past year, RXST quarterly EBIT has increased by +$2.87 million (+31.24%).
- RXST quarterly EBIT is now -120.60% below its all-time high of $30.68 million, reached on September 30, 2020.
Performance
RXST Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$30.65 M
+$5.85 M+16.03%
September 30, 2024
Summary
- As of February 7, 2025, RXST TTM earnings before interest & taxes is -$30.65 million, with the most recent change of +$5.85 million (+16.03%) on September 30, 2024.
- Over the past year, RXST TTM EBIT has increased by +$14.63 million (+32.30%).
- RXST TTM EBIT is now -179.16% below its all-time high of $38.72 million, reached on June 30, 2021.
Performance
RXST TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
RXST EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +26.7% | +31.2% | +32.3% |
| 3 y3 years | -260.9% | +31.2% | +32.3% |
| 5 y5 years | -135.9% | +31.2% | +32.3% |
RXST EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -0.6% | +26.7% | -4.3% | +61.8% | at high | +50.8% |
| 5 y | 5-year | -135.9% | +26.7% | -120.6% | +61.8% | -179.2% | +50.8% |
| alltime | all time | -135.9% | +26.7% | -120.6% | +61.8% | -179.2% | +50.8% |
RxSight EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$6.32 M(+4.3%) | -$30.65 M(-16.0%) |
| Jun 2024 | - | -$6.06 M(-33.3%) | -$36.51 M(-14.4%) |
| Mar 2024 | - | -$9.09 M(-1.2%) | -$42.66 M(-5.8%) |
| Dec 2023 | -$45.28 M(-26.7%) | -$9.19 M(-24.5%) | -$45.28 M(-9.9%) |
| Sep 2023 | - | -$12.17 M(-0.3%) | -$50.24 M(-6.2%) |
| Jun 2023 | - | -$12.21 M(+4.3%) | -$53.59 M(-5.9%) |
| Mar 2023 | - | -$11.71 M(-17.3%) | -$56.97 M(-7.8%) |
| Dec 2022 | -$61.80 M | -$14.15 M(-8.8%) | -$61.80 M(-0.8%) |
| Sep 2022 | - | -$15.52 M(-0.5%) | -$62.30 M(+6.7%) |
| Jun 2022 | - | -$15.60 M(-5.7%) | -$58.38 M(+5.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$16.53 M(+12.8%) | -$55.43 M(+23.2%) |
| Dec 2021 | -$45.00 M(-259.9%) | -$14.65 M(+26.3%) | -$45.00 M(+1167.9%) |
| Sep 2021 | - | -$11.60 M(-8.3%) | -$3.55 M(-109.2%) |
| Jun 2021 | - | -$12.65 M(+107.3%) | $38.72 M(+0.5%) |
| Mar 2021 | - | -$6.10 M(-122.8%) | $38.53 M(+36.9%) |
| Dec 2020 | $28.14 M(-77.7%) | $26.80 M(-12.6%) | $28.14 M(+1992.3%) |
| Sep 2020 | - | $30.68 M(-338.9%) | $1.34 M(-104.6%) |
| Jun 2020 | - | -$12.84 M(-22.2%) | -$29.33 M(+77.8%) |
| Mar 2020 | - | -$16.49 M | -$16.49 M |
| Dec 2019 | $126.27 M | - | - |
FAQ
- What is RxSight annual earnings before interest & taxes?
- What is the all time high annual EBIT for RxSight?
- What is RxSight annual EBIT year-on-year change?
- What is RxSight quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for RxSight?
- What is RxSight quarterly EBIT year-on-year change?
- What is RxSight TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for RxSight?
- What is RxSight TTM EBIT year-on-year change?
What is RxSight annual earnings before interest & taxes?
The current annual EBIT of RXST is -$45.28 M
What is the all time high annual EBIT for RxSight?
RxSight all-time high annual earnings before interest & taxes is $126.27 M
What is RxSight annual EBIT year-on-year change?
Over the past year, RXST annual earnings before interest & taxes has changed by +$16.52 M (+26.73%)
What is RxSight quarterly earnings before interest & taxes?
The current quarterly EBIT of RXST is -$6.32 M
What is the all time high quarterly EBIT for RxSight?
RxSight all-time high quarterly earnings before interest & taxes is $30.68 M
What is RxSight quarterly EBIT year-on-year change?
Over the past year, RXST quarterly earnings before interest & taxes has changed by +$2.87 M (+31.24%)
What is RxSight TTM earnings before interest & taxes?
The current TTM EBIT of RXST is -$30.65 M
What is the all time high TTM EBIT for RxSight?
RxSight all-time high TTM earnings before interest & taxes is $38.72 M
What is RxSight TTM EBIT year-on-year change?
Over the past year, RXST TTM earnings before interest & taxes has changed by +$14.63 M (+32.30%)